Center-Authored Papers

Browse: Authors | Keywords | All Center-Authored Publications
Filter by Division: Basic | Clinical | Human Biology | PHS | VIDD (2010-present) | VIDI (2008-2009)
Filter by Year: 2008 | 2009 | 2010 | 2011 | 2012 | 2013

Filters: Author is Martins, Renato G  [Clear All Filters]
B
Bauman, JE, Mulligan MS, Martins RG, Kurland BF, Eaton KD, Wood DE.  2008.  Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes.. The Annals of thoracic surgery. 86(5):1632-8;discussion1638-9. Abstract
Bauman, JE, Eaton KD, Wallace SG, Carr LL, Lee S-J, Jones DV, Arias-Pulido H, Cerilli LA, Martins RG.  2012.  A Phase II study of pulse dose imatinib mesylate and weekly paclitaxel in patients aged 70 and over with advanced non-small cell lung cancer.. BMC cancer. 12(1):449. Abstract
C
Carr, LL, Mankoff DA, Goulart BH, Eaton KD, Capell PT, Kell EM, Bauman JE, Martins RG.  2010.  Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation.. Clinical cancer research : an official journal of the American Association for Cancer Research. 16(21):5260-8. Abstract
E
Eaton, KD, Martins RG.  2010.  Maintenance chemotherapy in non-small cell lung cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. 8(7):815-21. Abstract
Ettinger, DS, Akerley W, Bepler G, Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Feigenberg SJ, Figlin RA et al..  2008.  Non-small cell lung cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. 6(3):228-69.
H
Hirsch, FR, Kabbinavar F, Eisen T, Martins RG, Schnell FM, Dziadziuszko R, Richardson K, Richardson F, Wacker B, Sternberg DW et al..  2011.  A Randomized, Phase II, Biomarker-Selected Study Comparing Erlotinib to Erlotinib Intercalated With Chemotherapy in First-Line Therapy for Advanced Non-Small-Cell Lung Cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(26):3567-3573. Abstract
K
Kalemkerian, GP, Akerley W, Downey RJ, Ettinger DS, Fossella F, Grecula JC, Jahan T, Johnson BE, Kessinger A, Koczywas M et al..  2008.  Small cell lung cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. 6(3):294-314.
M
Martins, RG, Parvathaneni U, Bauman JE, Sharma AK, Raez LE, Papagikos MA, Yunus F, Kurland BF, Eaton KD, Liao JJ et al..  2013.  Cisplatin and Radiotherapy With or Without Erlotinib in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Phase II Trial.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(11):1415-21. Abstract
Martins, RG, D'Amico TA, Loo BW, Pinder-Schenck M, Borghaei H, Chaft JE, Ganti AKP, Kong F-MS, Kris MG, Lennes IT et al..  2012.  The management of patients with stage IIIA non-small cell lung cancer with N2 mediastinal node involvement.. Journal of the National Comprehensive Cancer Network : JNCCN. 10(5):599-613. Abstract
R
Ramsey, SD, Martins RG, Blough DK, Tock LS, Lubeck D, Reyes CM.  2008.  Second-line and third-line chemotherapy for lung cancer: use and cost.. The American journal of managed care. 14(5):297-306. Abstract
T
Till, BG, Martins RG.  2008.  Response to paclitaxel in adenoid cystic carcinoma of the salivary glands.. Head & neck. 30(6):810-4. Abstract